Economy
assistanceEIB Board of Directors approved EUR 1 bn loan to Ukraine
The Board of Directors of the European Investment Bank (EIB) has approved a loan in the amount of EUR 1 bn to Ukraine, as a part of EUR 3 bn package of special measures for the country for the period of 2014-2016, according to the press service of EIB.
The EIB Board of Directors also approved the allocation of the EUR 50 mn loan to the international biotechnology company Bavarian Nordic to help find a vaccine against Ebola virus.
“The decisions on financing projects in Ukraine and assistance to the projects in finding solutions to the pandemic virus Ebola are evidence of that the EIB does not avoid the approval of the necessary decisions even under difficult and uncomfortable conditions,” said EIB President Werner Hoyer.
As a reminder, the EIB has planned to sign with Ukraine three agreements in the amount of EUR 1 bn by the end of the year. The EIB also plans to allocate EUR 200 mn loan for the Donbas.
Design, style, and all the contents of website www.capital.uaare protected by copyright and law. Any use of site materials is allowed only while meeting the requirements of reprinting terms and with the reference to www.capital.ua.Only materials in public domain can be used and adding of link and/or direct hyperlink open for search engines to immediate material address on www.capital.ua. The link/hyperlink should be placed in the sub-title or in the first paragraph of the material. Font size of the link or hyperlink should not be less than the font size of the main text in the material. Any use of materials that are in closed access and are only available to registered users is allowed only with the prior written permission of the copyright owner. Reprinting, copying, reproducing, modifying or any other use of materials published with the note 
of the agreement of syndication with Financial Times Limited are strictly prohibited. Use of materials which refers to France-Presse, Reuters, Interfax-Ukraine, Ukrainian News, UNIAN agencies is strictly prohibited. Materials marked 
are published as advertisements.
All rights reserved. © 2012 — 2016